Tuesday, September 27, 2022
Home Tags CBD Policy & Regulation

CBD Policy & Regulation Related News

Driving medical cannabis-based therapies forward with biotech

Driving medical cannabis-based therapies forward with biotech

Lorna Rothery spoke to David Bassa who leads various biotech activities focused on the development of novel cannabis-based solutions. With an impressive portfolio of entrepreneurial...
CBD Oil in Malta: The Ultimate Guide

CBD Oil in Malta: The Ultimate Guide

CBD experts, Dr. Hemp Me, explain purchasing CBD oil in Malta, the legalities, and the growing young industry on the Mediterranean island. CBD oil is...
Clinical trials needed to verify anti-inflammatory benefits of CBD

Clinical trials needed to verify anti-inflammatory benefits of CBD

High-quality, randomised clinical trials are needed to determine if the anti-inflammatory benefits of CBD seen in preclinical trials will be useful in a real...
Banking and finance in the medicinal cannabis industry

Banking and finance in the medicinal cannabis industry

Mitch Ratajkoski of LeafCann explores how the banking industry is limiting operations and growth for companies in the medicinal cannabis industry. Banking has become an...
recreational cannabis

Recreational cannabis access reduces prescription drug use in the US

A new study in the US has revealed that legalising recreational cannabis has significantly reduced the use of prescription medications. Performed by a team of...
Canada cannabis policy

Cannabis cultivation and policy in Canada

MCN speaks with Cannabis Council of Canada President George Smitherman about the cannabis landscape and policy in Canada.
brexit medical cannabis

Brexit will end medical cannabis access for sick children

Following the end of the UK’s Brexit transition period on 1 January 2021, British children with severe medical conditions will no longer be able...
EU court rules CBD is ‘not a narcotic’

EU court rules CBD is ‘not a narcotic’

In a landmark move the Court of Justice of the European Union (CJEU) has ruled the cannabinoid CBD is ‘not a narcotic’, as it...
fda cannabis

FDA: cannabis, COVID-19 and misinformation

The US FDA’s Center for Drug Evaluation and Research tells us about the hazards of untested and unapproved cannabis treatments. The US Center for Drug...
Discussing the need for evidence-based drug policy

Discussing the need for evidence-based drug policy

Science for Democracy co-founder and former Italian Senator Marco Perduca tells MCN about the need for evidence-based drug policy. International platform Science for Democracy (SfD)...
FDA given CBD regulation recommendations by NlHC

FDA given CBD regulation recommendations by NlHC

The National Industrial Hemp Council (NIHC) has recently given recommendations to the Food and Drug Administration (FDA) on CBD regulation. The NIHC, which provides high-quality...
Professor Mike Barnes outlines opportunity in the UK’s CBD market

Professor Mike Barnes outlines opportunity in the UK’s CBD market

The UK's CBD market has flourished despite the impact of COVID-19. The rest of the world has steamed ahead with the legalisation of medical and...
Currency UK: CBD, currency, and COVID-19

Currency UK: assessing the impact of COVID-19 on the CBD sector

Currency UK Head of Sales Ben Kohler assesses the impact of COVID-19 on foreign exchange within the CBD sector. With CBD still being a relatively...
Medical cannabis research and policy in Israel

Medical cannabis research and policy in Israel

Yuval Landschaft, Director of the Israeli Medical Cannabis Agency, outlines Israel’s regulatory approach to cannabis-based medical treatment. In recent years, there has been an increase...
Cannabis research, innovation, and policy in Australia

Cannabis research, innovation, and policy in Australia

Professor Jennifer Martin, Chair of Clinical Pharmacology at the University of Newcastle and Director of the Australia Centre for Cannabinoid Clinical and Research Excellence,...
The Center for Medicinal Cannabis Research with Dr Igor Grant

The Center for Medicinal Cannabis Research with Dr Igor Grant

In this article, Dr Igor Grant explores the work of the Center for Medicinal Cannabis Research. When the Center for Medicinal Cannabis Research at UC...
‘A national disgrace’: call to improve medical cannabis access in the UK

‘A national disgrace’: call to improve medical cannabis access in the UK

A campaigner has urged the UK government to improve access to medical cannabis prescriptions as restrictive guidance from NICE and the BPNA has meant...
Cannabis law and policy in Gibraltar

Cannabis law and policy in Gibraltar

Hassans International Law Firm Limited Partner Aaron Payas, CFA gives MCN an overview of Gibraltar’s cannabis landscape. In October 2019, the government of Gibraltar approved...
Medical Cannabis Network Quarterly Issue 3

Medical Cannabis Network Quarterly Issue 3

Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our third edition, which looks at cannabis research, policy, and national and international regulation of cannabis. Welcome...
White paper aims to accelerate cannabis integration into UK healthcare

White paper aims to accelerate cannabis integration into UK healthcare

A new white paper has been published by leaders in the cannabis field, showcasing how to maximise clinical research and improve patient access to...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest